Monthly Archives: November 2012

Firms Ally to Develop Humira Biosimilar

AET BioTech and BioXpress Therapeutics are pooling their expertise to develop a biosimilar version of Abbott’s billion-dollar TNF-α-blocking antibody adalimumab (Humira®). http://www.genengnews.com/gen-news-highlights/firms-ally-to-develop-humira-biosimilar/81247559

Posted in drugs | Leave a comment